Insights

  • Date

  • Content Type

  • Reset

Blog

Accelerating development through manufacturing best practices

17.01.22

By Kate Coleman, MSc.

The journey to commercialization can be fraught with challenges for organizations...

Blog

The Promise of Converging Disruptive Technologies in Advanced Therapy Production

11.01.22

By Yasser El-Sherbini

Advanced therapeutic medicinal products (ATMPs), better known as cell and gene therapy (CGT) in the United States...

Blog

Roadmap to commercialization success: Build agility into drug development plans

29.11.21

By Dr. Diane Seimetz

We know the lifechanging impact that gene, cell and tissue-based therapies..

Blog

The new economics of innovative therapies: Navigating emerging payment models

11.11.21

By Alberto Rubio

For years, market access strategies for new therapies almost exclusively depended on data supporting efficacy and safety. ..

Blog

Accelerating commercialization of advanced therapies: it’s time to map a new route to market

26.10.21

By Christian Schneider

For decades, advanced therapies have shown potential to disrupt the $1 trillion global pharmaceuticals...

Blog

Biopharma’s Big Inflection Point: There’s never been a better time to innovate with next-generation medicine

11.10.21

By Christian Schneider

In all of the years I have been tracking and helping to drive biotech innovation, I can say...